£10.0M
The financing round was led by BGF and Parkwalk Advisors to support platform expansion and team growth.
Enhanc3D Genomics
Enhanc3D Genomics develops functional genomics platforms that map the human three dimensional genome to transform therapeutic development.
£10.0MTotal raised
Enhanc3D Genomics is a functional genomics company that unlocks the potential of the human three-dimensional genome to transform therapeutic development. Its proprietary platform maps DNA interactions to identify novel disease biomarkers and treatment targets.
Categories
Team
CT
Chris Torrance
Non-Executive Chair
PF
Peter Fraser
Professor
DL
Debora Lucarelli
Chief Executive Officer
FA
Frank Armstrong
Dr
JM
Jonathan Milner
Private Investor